Corline Biomedical AB

OM:CLBIO Stock Report

Market Cap: SEK 476.9m

Corline Biomedical Future Growth

Future criteria checks 2/6

Corline Biomedical is forecast to grow revenue at 47.3% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth36.7%
Revenue growth rate47.3%
Future return on equityn/a
Analyst coverage

Low

Last updated11 May 2026

Recent future growth updates

Recent updates

Analysis Article • May 11

We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Aug 24

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Mar 15

We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Nov 26

We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Jun 22

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Feb 16

We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article • Jun 14

Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Analysis Article • Feb 28

Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Earnings and Revenue Growth Forecasts

OM:CLBIO - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028143N/AN/AN/A1
12/31/202795N/AN/AN/A1
12/31/202642N/AN/A161
3/31/202611-14-19-18N/A
12/31/20259-15-19-18N/A
9/30/20259-24-18-17N/A
6/30/202510-23-21-19N/A
3/31/202514-25-23-17N/A
12/31/202417-23-16-9N/A
9/30/202424-10-100N/A
6/30/202429-6-92N/A
3/31/202431-4-37N/A
12/31/202336-2-101N/A
9/30/202337-1-12-2N/A
6/30/2023401-120N/A
3/31/2023384-16-5N/A
12/31/2022332-15-6N/A
9/30/2022311-14-2N/A
6/30/202223-3-15-6N/A
3/31/202219-6-16-6N/A
12/31/202117-7-14-5N/A
9/30/202115-6-12-6N/A
6/30/202113-6-12-7N/A
3/31/202114-6-12-6N/A
12/31/202015-7-14-5N/A
9/30/202014-9-20-7N/A
6/30/202014-9-20-9N/A
3/31/202014-9-20-11N/A
12/31/201912-10N/A-14N/A
9/30/201911-9N/A-17N/A
6/30/201911-9N/A-5N/A
3/31/201910-8N/A-4N/A
12/31/201810-7N/A-4N/A
9/30/201817-7N/A-6N/A
6/30/201816-6N/A-15N/A
3/31/201815-7N/A-16N/A
12/31/201716-8N/A-5N/A
9/30/20177-8N/A-2N/A
6/30/20179-8N/A-2N/A
3/31/201710-6N/A1N/A
12/31/20169-5N/A-7N/A
9/30/20168-6N/A-5N/A
6/30/20167-6N/A-4N/A
3/31/20165-7N/A-5N/A
12/31/20154-6N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CLBIO's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if CLBIO's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if CLBIO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CLBIO's revenue (47.3% per year) is forecast to grow faster than the Swedish market (0.04% per year).

High Growth Revenue: CLBIO's revenue (47.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CLBIO's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 00:12
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corline Biomedical AB is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gustaf MeyerRedeye